Pseudotype formation with La Crosse virus glycoproteins

被引:4
|
作者
Bupp, K
González-Scarano, F
机构
[1] Univ Penn, Med Ctr, Dept Microbiol, Philadelphia, PA 19104 USA
[2] Univ Penn, Med Ctr, Dept Neurol, Philadelphia, PA 19104 USA
来源
关键词
D O I
10.1099/0022-1317-79-4-667
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Pseudotype formation is a powerful tool for analysing mechanisms of virus neutralization and entry, since it allows for analysis of glycoprotein properties without the necessity for preparing recombinant genomes, Using recombinant vaccinia viruses, we prepared pseudotypes of La Crosse virus with recombinant glycoproteins cloned from the monoclonal antibody (MAb)-resistant variant V31. The resulting pseudotypes became partially resistant to MAb 807-31. Furthermore, when the V31 glycoproteins were incorporated into a second MAb-resistant variant (V33), the pseudotyped virus became sensitive to neutralization by the MAb (807-33) originally used in its selection. These results suggest a simple technique for the incorporation of glycoprotein mutations into bunyaviruses, allowing analysis of mechanisms of neutralization and other virus entry functions.
引用
收藏
页码:667 / 671
页数:5
相关论文
共 50 条
  • [1] Analysis of the intracellular transport properties of recombinant La Crosse virus glycoproteins
    Bupp, K
    Stillmock, K
    GonzalezScarano, F
    [J]. VIROLOGY, 1996, 220 (02) : 485 - 490
  • [2] La Crosse virus encephalitis in children
    Ouellette, Christopher P.
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2024, 37 (05) : 419 - 424
  • [3] Entry and fusion of La Crosse virus
    Hollidge, Bradley S.
    Soldan, Samantha S.
    Wagner, Valentia
    Weber, Friedmann
    Gonzalez-Scarano, Francisco
    [J]. JOURNAL OF NEUROVIROLOGY, 2010, 16 : 37 - 38
  • [4] An Overview of La Crosse Virus Disease
    Matthews, Elizabeth
    Chauhan, Lakshmi
    Piquet, Amanda L.
    Tyler, Kenneth L.
    Pastula, Daniel M.
    [J]. NEUROHOSPITALIST, 2022, 12 (03): : 587 - 588
  • [5] STRUCTURAL PROTEINS OF LA CROSSE VIRUS
    OBIJESKI, JF
    BISHOP, DHL
    MURPHY, FA
    PALMER, EL
    [J]. JOURNAL OF VIROLOGY, 1976, 19 (03) : 985 - 997
  • [6] DNA vaccination against La Crosse virus
    Pavlovic, J
    Schultz, J
    Hefti, HP
    Schuh, T
    Mölling, K
    [J]. INTERVIROLOGY, 2000, 43 (4-6) : 312 - 321
  • [7] Functional features of hepatitis C virus glycoproteins for pseudotype virus entry into mammalian cells
    Meyer, K
    Basu, A
    Ray, R
    [J]. VIROLOGY, 2000, 276 (01) : 214 - 226
  • [8] Innate immune response to La Crosse virus infection
    Katherine G. Taylor
    Karin E. Peterson
    [J]. Journal of NeuroVirology, 2014, 20 : 150 - 156
  • [9] Characterization of infectious retroviral pseudotype particles bearing hepatitis C virus glycoproteins
    Flint, M
    Logvinoff, C
    Rice, CM
    McKeating, JA
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (13) : 6875 - 6882
  • [10] Potential for La Crosse virus segment reassortment in nature
    Reese, Sara M.
    Blitvich, Bradley J.
    Blair, Carol D.
    Geske, Dave
    Beaty, Barry J.
    Black, William C.
    [J]. VIROLOGY JOURNAL, 2008, 5 (1)